Thumbnail Image
Publication

Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations

Turner, NC
; 
Laird, AD
; 
Telli, ML
; 
Rugo, HS
; 
Mailliez, A
; 
Ettl, J
; 
Grischke, EM
; 
Mina, LA
; 
Balmana, J
; 
Fasching, PA
... show 8 more
Citations
Altmetric:
Abstract
Authors
Turner, NC
Laird, AD
Telli, ML
Rugo, HS
Mailliez, A
Ettl, J
Grischke, EM
Mina, LA
Balmana, J
Fasching, PA
Hurvitz, SA
Albacker, LA
Frampton, GM
Chelliserry, J
Bycott, P
Conte, U
Wardley, Andrew M
Robson, ME
Affiliation
Molecular Oncology, Royal Marsden Hospital, The Institute of Cancer Research, London,
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL. Conference abstract
Adobe PDF, 92.93 KB
Keywords
Type
Meetings and Proceedings
Citation
Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, et al. 314P Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations. Annals of Oncology. 2019;30(Supplement_5):108.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622581
Embedded videos